[Retracted] Identification of the Novel Methylated Genes’ Signature to Predict Prognosis in INRG High-Risk Neuroblastomas

Table 1

Summary of patient characteristics and demographics.

Characteristic	Number of cases (%) in the training set	Number of cases (%) in the testing set
Gender
Male	47 (54.7%)	29 (82.6%)
Female	39 (45.3%)	15 (17.4%)
Age
<18 months	2 (2.3%)	2 (2.3%)
≥18 months	86 (97.7%)	42 (97.7%)
MYCN status
Amplified	31 (36.0%)	17 (38.6%)
Not amplified	54 (62.8%)	27 (61.4%)
NA	1 (1.2%)
INSS stage
1	0 (0.0%)	0 (0.0%)
2	0 (0.0%)	0 (0.0%)
3	2 (2.3%)	0 (0.0%)
4	84 (97.7%)	43 (97.7%)
4s	0 (0.0%)	1 (2.3%)
INRG
Low risk	0 (0.0%)	0 (0.0%)
Intermediate risk	0 (0.0%)	0 (0.0%)
High risk	89 (100%)	44 (100%)
Vital status
Living	35 (40.7%)	20 (55.5%)
Dead	51 (59.3%)	24 (54.5%)